top of page
Ezetimibe

依折麥布
Mechanism of action:
Ezetimibe 是一種膽固醇吸收抑制劑(cholesterol absorption inhibitor)。Ezetimibe 能抑制NPC1L1 轉運蛋白的活性。NPC1L1(Niemann-Pick C1-Like 1)是小腸上皮細胞負責吸收膽固醇的重要轉運蛋白。當 ezetimibe 抑制 NPC1L1 後,能阻止飲食中的膽固醇與膽汁中膽固醇進入腸上皮細胞。
Reference(s):
1. Garcia-Calvo M et al. (2005). The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1). Proc Natl Acad Sci USA.
2. Phan BA et al. (2012). Ezetimibe therapy: mechanism of action and clinical update. Vasc Health Risk Manag.
bottom of page
